21 results
6-K
EX-1.1
IPHA
Innate Pharma
6 Feb 24
Current report (foreign)
5:05pm
share option, incentive or benefit plan, share purchase or ownership plan, long-term incentive plan, dividend reinvestment plan, inducement award
424B5
IPHA
Innate Pharma
6 Feb 24
Prospectus supplement for primary offering
5:00pm
in this offering
To the extent that options or warrants are exercised, new options are issued under our existing or future equity incentive plans, or we issue
6-K
EX-1.1
IPHA
Innate Pharma
26 Apr 23
Current report (foreign)
4:02pm
share option, incentive or benefit plan, share purchase or ownership plan, long-term incentive plan, dividend reinvestment plan, inducement award
424B5
x5d9q nyi7kea2xwfxe4
26 Apr 23
Prospectus supplement for primary offering
4:01pm
6-K
EX-1.1
8ygpasrr yxrvgiwn0
3 May 22
Current report (foreign)
5:08pm
424B5
iz4za5ragwl1pl4
3 May 22
Prospectus supplement for primary offering
4:36pm
S-8
EX-99.1
vxywfrzziu7 ext
12 Jul 21
Registration of securities for employees
1:42pm
6-K
EX-99.2
c21 4l8qli
8 Sep 20
Innate Pharma Reports First Half 2020 Financial Results and Business Update
6:10am
20-F
q05cvublba2f1sm0v
24 Apr 20
Annual report (foreign)
10:43am
424B4
jhgj9 pwf3pgwq6
18 Oct 19
Prospectus supplement with pricing info
4:08pm
F-1/A
4yl2x4q
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1/A
EX-1.1
mwoi52ezra4u8kg1f
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1
53zvd 1mk7
20 Sep 19
Registration statement (foreign)
4:08pm
DRS/A
g3uhbru 3j6
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
tvuuctkl
19 Jul 19
Draft registration statement (amended)
12:00am